Vascularization of the dorsal root ganglia and peripheral nerve of the mouse: Implications for chemical-induced peripheral sensory neuropathies
详细信息 查看全文
- 作者：Juan M Jimenez-Andrade (1)
Monica B Herrera (1)
Joseph R Ghilardi (2)
Marina Vardanyan (1)
Ohannes K Melemedjian (1)
Patrick W Mantyh (1) (2) - 刊名：Molecular Pain
- 出版年：2008
- 出版时间：December 2008
- 年：2008
- 卷：4
- 期：1
- 全文大小：4138KB
- 参考文献：1. Le Quesne PM: Neuropathy due to drugs. / Peripheral Neuropathy / (Edited by: Dyck PF, Thomas PK, Lambert EH). Philadelphia , Saunders 1975.
2. Cavanagh JB: Peripheral neuropathy caused by chemical agents. / CRC Crit Rev Toxicol 1973,2(3):365鈥?17. CrossRef
3. Cho ES, Schaumburg HH, Spencer PS: Adriamycin produces ganglioradiculopathy in rats. / J Neuropathol Exp Neurol 1977, 36:907鈥?15. CrossRef
4. Hopkins A: Toxic neuropathy due to industrial agents. / Peripheral Neuropathy / (Edited by: Dyck PF, Thomas PK, Lambert EH). Philadelphia , Saunders 1975.
5. Grant MW: Toxicology of the eye. / Toxicology of the eye / (Edited by: Thomas CC). Illinois , Springfield 1974, 96.
6. Le Quesne PM, McLeod JG: Peripheral neuropathy following a single exposure to arsenic. Clincal course in four patients with electrophysiological and histological studies. / J Neurol Sci 1977,32(3):437鈥?51. CrossRef
7. Viaene MK, Roels HA, Leenders J, De Groof M, Swerts LJ, Lison D, Masschelein R: Cadmium: a possible etiological factor in peripheral polyneuropathy. / Neurotoxicology 1999,20(1):7鈥?6.
8. Ikeda Y, Tobe M, Kobayashi K, Suzuki S, Kawasaki Y: Long-term toxicity study of methylmercuric chloride in monkeys (first report). / Toxicology 1973,1(4):361鈥?75. CrossRef
9. Somjen GG, Herman SP, Klein R, Brubaker PE, Briner WH, Goodrich JK, Krigman MR, Haseman JK: The uptake of methyl mercury (203Hg) in different tissues related to its neurotoxic effects. / J Pharmacol Exp Ther 1973,187(3):602鈥?11.
10. Arvidson B, Tjalve H: Distribution of 109Cd in the nervous system of rats after intravenous injection. / Acta Neuropathol 1986,69(1鈥?):111鈥?16. CrossRef
11. Lee JJ, Swain SM: Peripheral neuropathy induced by microtubule-stabilizing agents. / J Clin Oncol 2006,24(10):1633鈥?642. CrossRef
12. Quasthoff S, Hartung HP: Chemotherapy-induced peripheral neuropathy. / J Neurol 2002,249(1):9鈥?7. CrossRef
13. Mielke S, Sparreboom A, Mross K: Peripheral neuropathy: A persisting challenge in paclitaxel-based regimes. / Eur J Cancer 2006,42(1):24鈥?0. CrossRef
14. Pignata S, De Placido S, Biamonte R, Scambia G, Di Vagno G, Colucci G, Febbraro A, Marinaccio M, Lombardi AV, Manzione L, Carteni G, Nardi M, Danese S, Valerio MR, de Matteis A, Massidda B, Gasparini G, Di Maio M, Pisano C, Perrone F: Residual neurotoxicity in ovarian cancer patients in clinical remission after first-line chemotherapy with carboplatin and paclitaxel: the Multicenter Italian Trial in Ovarian cancer (MITO-4) retrospective study. / BMC Cancer 2006, 6:5. CrossRef
15. Pardo CA, McArthur JC, Griffin JW: HIV neuropathy: insights in the pathology of HIV peripheral nerve disease. / J Peripher Nerv Syst 2001,6(1):21鈥?7. CrossRef
16. Pettersen JA, Jones G, Worthington C, Krentz HB, Keppler OT, Hoke A, Gill MJ, Power C: Sensory neuropathy in human immunodeficiency virus/acquired immunodeficiency syndrome patients: protease inhibitor-mediated neurotoxicity. / Ann Neurol 2006,59(5):816鈥?24. CrossRef
17. McArthur JC, Brew BJ, Nath A: Neurological complications of HIV infection. / Lancet Neurol 2005,4(9):543鈥?55. CrossRef
18. Berger AR, Arezzo JC, Schaumburg HH, Skowron G, Merigan T, Bozzette S, Richman D, Soo W: 2',3'-dideoxycytidine (ddC) toxic neuropathy: a study of 52 patients. / Neurology 1993,43(2):358鈥?62.
19. Keswani SC, Pardo CA, Cherry CL, Hoke A, McArthur JC: HIV-associated sensory neuropathies. / Aids 2002,16(16):2105鈥?117. CrossRef
20. Nicholas PK, Mauceri L, Slate Ciampa A, Corless IB, Raymond N, Barry DJ, Viamonte Ros A: Distal sensory polyneuropathy in the context of HIV/AIDS. / J Assoc Nurses AIDS Care 2007,18(4):32鈥?0. CrossRef
21. Nicholas PK, Kemppainen JK, Canaval GE, Corless IB, Sefcik EF, Nokes KM, Bain CA, Kirksey KM, Eller LS, Dole PJ, Hamilton MJ, Coleman CL, Holzemer WL, Reynolds NR, Portillo CJ, Bunch EH, Wantland DJ, Voss J, Phillips R, Tsai YF, Mendez MR, Lindgren TG, Davis SM, Gallagher DM: Symptom management and self-care for peripheral neuropathy in HIV/AIDS. / AIDS Care 2007,19(2):179鈥?89. CrossRef
22. Aghajanian C, Fennelly D, Shapiro F, Waltzman R, Almadrones L, O'Flaherty C, O'Conner K, Venkatraman E, Barakat R, Curtin J, Brown C, Reich L, Wuest D, Norton L, Hoskins W, Spriggs DR: Phase II study of "dose-dense" high-dose chemotherapy treatment with peripheral-blood progenitor-cell support as primary treatment for patients with advanced ovarian cancer. / J Clin Oncol 1998,16(5):1852鈥?860.
23. Pasini F, Durante E, De Manzoni D, Rosti G, Pelosi G: High-dose chemotherapy in small-cell lung cancer. / Anticancer Res 2002,22(6B):3465鈥?472.
24. Cocconi G, Bella M, Lottici R, Leonardi F, Ceci G, Passalacqua R, Di Blasio B, Bordi C, Biscottini B, Melpignano M, De Biasi D, Finardi C, Bacchi M: Mature results of a prospective randomized trial comparing a three-weekly with an accelerated weekly schedule of cisplatin in advanced ovarian carcinoma. / Am J Clin Oncol 1999,22(6):559鈥?67. CrossRef
25. Sleeman JP, Krishnan J, Kirkin V, Baumann P: Markers for the lymphatic endothelium: in search of the holy grail? / Microsc Res Tech 2001,55(2):61鈥?9. CrossRef
26. Kivela R, Havas E, Vihko V: Localisation of lymphatic vessels and vascular endothelial growth factors-C and -D in human and mouse skeletal muscle with immunohistochemistry. / Histochem Cell Biol 2007,127(1):31鈥?0. CrossRef
27. Odaka C, Morisada T, Oike Y, Suda T: Distribution of lymphatic vessels in mouse thymus: immunofluorescence analysis. / Cell Tissue Res 2006,325(1):13鈥?2. CrossRef
28. Feng G, Mellor RH, Bernstein M, Keller-Peck C, Nguyen QT, Wallace M, Nerbonne JM, Lichtman JW, Sanes JR: Imaging neuronal subsets in transgenic mice expressing multiple spectral variants of GFP. / Neuron 2000,28(1):41鈥?1. CrossRef
29. Chen YS, Chung SS, Chung SK: Noninvasive monitoring of diabetes-induced cutaneous nerve fiber loss and hypoalgesia in thy1-YFP transgenic mice. / Diabetes 2005,54(11):3112鈥?118. CrossRef
30. Ireland WP, Fletcher TF, Bingham C: Quantification of microvasculature in the canine spinal cord. / Anat Rec 1981,200(1):102鈥?13. CrossRef
31. Dunning HS, Wolff HG: The relative vascularity of various parts of the central and peripheral nervous system of the cat and its relation to function. / J Comp Neurol 1937,31(3):433鈥?50. CrossRef
32. Hirakawa H, Okajima S, Nagaoka T, Kubo T, Takamatsu T, Oyamada M: Regional differences in blood-nerve barrier function and tight-junction protein expression within the rat dorsal root ganglion. / Neuroreport 2004,15(3):405鈥?08. CrossRef
33. Jacobs JM: Vascular permeability and neurotoxicity. / Environ Health Perspect 1978, 26:107鈥?16. CrossRef
34. Anzil AP, Blinzinger K, Herrlinger H: Fenestrated blood capillaries in rat cranio-spinal sensory ganglia. / Cell Tissue Res 1976,167(4):563鈥?67. CrossRef
35. Jacobs JM, Macfarlane RM, Cavanagh JB: Vascular leakage in the dorsal root ganglia of the rat, studied with horseradish peroxidase. / J Neurol Sci 1976,29(1):95鈥?07. CrossRef
36. Olsson Y: Topographical differences in the vascular permeability of the peripheral nervous system. / Acta Neuropathol (Berl) 1968,10(1):26鈥?3. CrossRef
37. Arvidson B: Distribution of intravenously injected protein tracers in peripheral ganglia of adult mice. / Exp Neurol 1979,63(2):388鈥?10. CrossRef
38. Devor M: Unexplained peculiarities of the dorsal root ganglion. / Pain 1999, Suppl 6:S27鈥?5. CrossRef
39. Schionning JD, Danscher G: Autometallographic mercury correlates with degenerative changes in dorsal root ganglia of rats intoxicated with organic mercury. / Apmis 1999,107(3):303鈥?10. CrossRef
40. Cavaletti G, Cavalletti E, Oggioni N, Sottani C, Minoia C, D'Incalci M, Zucchetti M, Marmiroli P, Tredici G: Distribution of paclitaxel within the nervous system of the rat after repeated intravenous administration. / Neurotoxicology 2000,21(3):389鈥?93.
41. Holmes J, Stanko J, Varchenko M, Ding H, Madden VJ, Bagnell CR, Wyrick SD, Chaney SG: Comparative neurotoxicity of oxaliplatin, cisplatin, and ormaplatin in a Wistar rat model. / Toxicol Sci 1998,46(2):342鈥?51.
42. Peters CM, Jimenez-Andrade JM, Ghilardi JR, Mantyh PW: An evolving cellular pathology occurs in dorsal root ganglia, peripheral nerve and spinal cord following intravenous administration of paclitaxel in the rat. / Brain Res 2007, 1168:46鈥?9. CrossRef
43. Kumamoto T, Fukuhara N, Miyatake T, Araki K, Takahashi Y, Araki S: Experimental neuropathy induced by methyl mercury compounds: autoradiographic study of GABA uptake by dorsal root ganglia. / Eur Neurol 1986,25(4):269鈥?77. CrossRef
44. Sacktor N: The epidemiology of human immunodeficiency virus-associated neurological disease in the era of highly active antiretroviral therapy. / J Neurovirol 2002, 8 Suppl 2:115鈥?21. CrossRef
45. Einzig AI, Wiernik PH, Wadler S, Kaplan J, Benson LT, Tentoramano L, Tan V: Phase I study of paclitaxel (taxol) and granulocyte colony stimulating factor (G-CSF) in patients with unresectable malignancy. / Invest New Drugs 1998,16(1):29鈥?6. CrossRef
46. Jimenez-Andrade JM, Peters CM, Mejia NA, Ghilardi JR, Mantyh PW: Sensory neurons and their supporting cells located in the trigeminal, thoracic and lumbar ganglia differentially express markers of injury follwing intravenous administration of paclitaxel in the rat. / Neurosci Lett 2006,405(1鈥?):62鈥?7. CrossRef
47. Peters CM, Jimenez-Andrade JM, Jonas BM, Sevcik MA, Koewler NJ, Ghilardi JR, Wong GY, Mantyh PW: Intravenous paclitaxel administration in the rat induces a peripheral sensory neuropathy characterized by macrophage infiltration and injury to sensory neurons and their supporting cells. / Exp Neurol 2007,203(1):42鈥?4. CrossRef
48. Seijffers R, Allchorne AJ, Woolf CJ: The transcription factor ATF-3 promotes neurite outgrowth. / Mol Cell Neurosci 2006,32(1鈥?):143鈥?54. CrossRef
49. Tsujino H, Kondo E, Fukuoka T, Dai Y, Tokunaga A, Miki K, Yonenobu K, Ochi T, Noguchi K: Activating transcription factor 3 (ATF3) induction by axotomy in sensory and motoneurons: A novel neuronal marker of nerve injury. / Mol Cell Neurosci 2000,15(2):170鈥?82. CrossRef
50. Krarup-Hansen A, Rietz B, Krarup C, Heydorn K, Rorth M, Schmalbruch H: Histology and platinum content of sensory ganglia and sural nerves in patients treated with cisplatin and carboplatin: an autopsy study. / Neuropathol Appl Neurobiol 1999,25(1):29鈥?0. CrossRef
51. Bradley WG, Shapshak P, Delgado S, Nagano I, Stewart R, Rocha B: Morphometric analysis of the peripheral neuropathy of AIDS. / Muscle Nerve 1998,21(9):1188鈥?195. CrossRef
52. Parmar MK, Ledermann JA, Colombo N, du Bois A, Delaloye JF, Kristensen GB, Wheeler S, Swart AM, Qian W, Torri V, Floriani I, Jayson G, Lamont A, Trope C: Paclitaxel plus platinum-based chemotherapy versus conventional platinum-based chemotherapy in women with relapsed ovarian cancer: the ICON4/AGO-OVAR-2.2 trial. / Lancet 2003,361(9375):2099鈥?106. CrossRef
53. Bhagra A, Rao RD: Chemotherapy-induced Neuropathy. / Curr Oncol Rep 2007,9(4):290鈥?99. CrossRef
54. Forman AD: Peripheral neuropathy and cancer. / Curr Oncol Rep 2004,6(1):20鈥?5. CrossRef
55. Maindrault-Goebel F, de Gramont A, Louvet C, Andre T, Carola E, Mabro M, Artru P, Gilles V, Lotz JP, Izrael V, Krulik M: High-dose intensity oxaliplatin added to the simplified bimonthly leucovorin and 5-fluorouracil regimen as second-line therapy for metastatic colorectal cancer (FOLFOX 7). / Eur J Cancer 2001,37(8):1000鈥?005. CrossRef
56. Grothey A: Oxaliplatin-safety profile: neurotoxicity. / Semin Oncol 2003,30(4 Suppl 15):5鈥?3. CrossRef
57. Mantyh PW: Cancer pain and its impact on diagnosis, survival and quality of life. / Nat Rev Neurosci 2006,7(10):797鈥?09. CrossRef
58. Faden AI, Stoica B: Neuroprotection: challenges and opportunities. / Arch Neurol 2007,64(6):794鈥?00. CrossRef
59. Cata JP, Weng HR, Lee BN, Reuben JM, Dougherty PM: Clinical and experimental findings in humans and animals with chemotherapy-induced peripheral neuropathy. / Minerva Anestesiol 2006,72(3):151鈥?69.
60. Glaser J, Gonzalez R, Perreau VM, Cotman CW, Keirstead HS: Neutralization of the chemokine CXCL10 enhances tissue sparing and angiogenesis following spinal cord injury. / J Neurosci Res 2004,77(5):701鈥?08. CrossRef
61. Weidner N, Semple JP, Welch WR, Folkman J: Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma. / N Engl J Med 1991,324(1):1鈥?. CrossRef - 作者单位：Juan M Jimenez-Andrade (1)
Monica B Herrera (1)
Joseph R Ghilardi (2)
Marina Vardanyan (1)
Ohannes K Melemedjian (1)
Patrick W Mantyh (1) (2)
1. Department of Pharmacology, College of Medicine, University of Arizona, 85724, Tucson, AZ, USA
2. Research Service, VA Medical Center, 55417, Minneapolis, MN, USA
文摘
Although a variety of industrial chemicals, as well as several chemotherapeutic agents used to treat cancer or HIV, preferentially induce a peripheral sensory neuropathy what remains unclear is why these agents induce a sensory vs. a motor or mixed neuropathy. Previous studies have shown that the endothelial cells that vascularize the dorsal root ganglion (DRG), which houses the primary afferent sensory neurons, are unique in that they have large fenestrations and are permeable to a variety of low and high molecular weight agents. In the present report we used whole-mount preparations, immunohistochemistry, and confocal laser scanning microscopy to show that the cell body-rich area of the L4 mouse DRG has a 7 fold higher density of CD31+ capillaries than cell fiber rich area of the DRG or the distal or proximal aspect of the sciatic nerve. This dense vascularization, coupled with the high permeability of these capillaries, may synergistically contribute, and in part explain, why many potentially neurotoxic agents preferentially accumulate and injure cells within the DRG. Currently, cancer survivors and HIV patients constitute the largest and most rapidly expanding groups that have chemically induced peripheral sensory neuropathy. Understanding the unique aspects of the vascularization of the DRG and closing the endothelial fenestrations of the rich vascular bed of capillaries that vascularize the DRG before intravenous administration of anti-neoplastic or anti-HIV therapies, may offer a mechanism based approach to attenuate these chemically induced peripheral neuropathies in these patients.